probenecid has been researched along with Cancer of Skin in 2 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Hanouna, G | 1 |
Tang, E | 1 |
Perez, J | 1 |
Vandermeersch, S | 1 |
Haymann, JP | 1 |
Baud, L | 1 |
Letavernier, E | 1 |
Gupta, S | 1 |
Aggarwal, S | 1 |
Nakamura, S | 1 |
2 other studies available for probenecid and Cancer of Skin
Article | Year |
---|---|
Preventing Calpain Externalization by Reducing ABCA1 Activity with Probenecid Limits Melanoma Angiogenesis and Development.
Topics: Animals; ATP Binding Cassette Transporter 1; Calcium-Binding Proteins; Calpain; Cell Line, Tumor; Ce | 2020 |
A possible role of multidrug resistance-associated protein (MRP) in basic fibroblast growth factor secretion by AIDS-associated Kaposi's sarcoma cells: a survival molecule?
Topics: AIDS-Related Opportunistic Infections; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Mem | 1998 |